Online inquiry

IVTScrip™ mRNA-Human ABLIM1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8778MR)

This product GTTS-WK8778MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ABLIM1 protein. This product can be used in Naive CD8+ T cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001003407.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 3983
UniProt ID O14639
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ABLIM1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8778MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK9489MR IVTScrip™ mRNA-Human ADAM12, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAM12
GTTS-WK18807MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK23195MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP30
GTTS-WK27470MR IVTScrip™ mRNA-Human ARPC4-TTLL3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARPC4-TTLL3
GTTS-WK17317MR IVTScrip™ mRNA-Human ANKRD31, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ANKRD31
GTTS-WK28585MR IVTScrip™ mRNA-Human ARHGAP18, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP18
GTTS-WK12837MR IVTScrip™ mRNA-Human ADGRE2, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADGRE2
GTTS-WK7785MR IVTScrip™ mRNA-Human AFG3L2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AFG3L2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW